COM:EDGEWISETX

Edgewise Therapeutics

Stock

Last Close

31.98

22/11 21:00

Market Cap

2.01B

Beta: -

Volume Today

352.86K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-9.71M -	-17.12M 76.43%	-42.81M 150.03%	-67.64M 57.99%	-100.16M 48.08%
depreciation and amortization	123K -	185K 50.41%	272K 47.03%	538K 97.79%	1.73M 221.93%
deferred income tax	-48K -	-203K 322.92%	-2.29M 1,030.05%
stock based compensation	77K -	354K 359.74%	4.40M 1,144.07%	10.92M 148.05%	17.56M 60.75%
change in working capital	334K -	1.95M 483.83%	4.63M 137.44%	4.09M 11.75%	-1.56M 138.18%
accounts receivables
inventory
accounts payables	275K -	521K 89.45%	2.65M 409.40%	47K 98.23%	-92K 295.74%
other working capital	59K -	1.43M 2,322.03%	1.98M 38.28%	4.04M 104.40%	-1.47M 136.35%
other non cash items	48K -	203K 322.92%	2.29M 1,030.05%	-543K 123.67%	-9.52M 1,652.67%
net cash provided by operating activities	-9.17M -	-14.63M 59.57%	-33.51M 128.97%	-52.63M 57.09%	-91.95M 74.69%
investments in property plant and equipment	-180K -	-203K 12.78%	-668K 229.06%	-5.55M 730.24%	-5.75M 3.59%
acquisitions net			241.56K -	65.03K 73.08%
purchases of investments		-24.18M -	-288.20M 1,092.01%	-292.39M 1.45%	-255.87M 12.49%
sales maturities of investments			46.64M -	227.36M 387.43%	364.50M 60.32%
other investing activites			-241.56K -	-65.03K 73.08%
net cash used for investing activites	-180K -	-24.38M 13,445.00%	-242.23M 893.51%	-70.58M 70.86%	102.89M 245.78%
debt repayment
common stock issued	24.80M -	120.28M 384.99%	186.15M 54.76%	129.16M 30.61%	52.62M 59.26%
common stock repurchased
dividends paid
other financing activites	24.80K -	120.28K 384.99%	236K 96.21%	474K 100.85%	548K 15.61%
net cash used provided by financing activities	24.80M -	120.28M 384.99%	186.38M 54.96%	129.64M 30.45%	53.17M 58.99%
effect of forex changes on cash
net change in cash	15.45M -	81.26M 426.01%	-89.35M 209.95%	6.43M 107.19%	64.10M 897.42%
cash at beginning of period	8.20M -	23.65M 188.31%	104.92M 343.56%	15.57M 85.16%	21.99M 41.29%
cash at end of period	23.65M -	104.92M 343.56%	15.57M 85.16%	21.99M 41.29%	86.10M 291.47%
operating cash flow	-9.17M -	-14.63M 59.57%	-33.51M 128.97%	-52.63M 57.09%	-91.95M 74.69%
capital expenditure	-180K -	-203K 12.78%	-668K 229.06%	-5.55M 730.24%	-5.75M 3.59%
free cash flow	-9.35M -	-14.84M 58.67%	-34.17M 130.34%	-58.18M 70.24%	-97.69M 67.91%

All numbers in (except ratios and percentages)